IBA, Beximco Pharma sign MoU for executive training programme

The Institute of Business Administration (IBA) of the University of Dhaka and Beximco Pharmaceuticals PLC on Tuesday signed a memorandum of understanding (MoU) to jointly launch an executive training programme titled “Advanced Certificate in Pharmaceutical Business Administration (ACPBA).”

The agreement was signed by IBA Director Prof Dr Abu Yusuf Md Abdullah and Beximco Pharmaceuticals Chief Operating Officer Rabbur Reza on behalf of their respective organisations.

Speaking at the signing ceremony, the speakers stressed the need for stronger collaboration between academia and industry to develop skilled professionals for Bangladesh's pharmaceutical sector.

Among others, Prof Dr Md Mohiuddin, moderator of the ACPBA programme at IBA, MA Arshad Bhuiyan, executive director and head of human resources at Beximco Pharmaceuticals, addressed the event.

Under the agreement, IBA will conduct the ACPBA programme to strengthen the professional and managerial competencies of Beximco Pharmaceuticals employees. The course is designed to provide participants with advanced knowledge and practical skills in business administration, leadership, management and pharmaceutical business in line with the evolving needs of the industry.

Each batch will run for around six months, comprising 40 sessions and a total of 120 training hours. Four batches, each accommodating up to 40 participants, will be organised over the next two years through mutual agreement.

The programme will be delivered by IBA faculty members along with experienced senior executives from the pharmaceutical industry. The training will include lectures, case studies, group exercises, workshops and presentations.

Participants who successfully complete the programme will receive a certificate from the Institute of Business Administration (IBA), University of Dhaka.